Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.5.4, updating the site version reference. This reflects a new build of the page template and does not alter study data or visible content.
    Difference
    0.0%
    Check dated 2026-05-16T09:12:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site release.
    Difference
    0.0%
    Check dated 2026-04-24T17:01:59.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:41:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Study Record Dates were updated with new update entries (2026-04-02, 2026-04-01, 2026-03) and removal of older entries (2026-02-02, 2026-01-30, 2026-01).
    Difference
    0.2%
    Check dated 2026-04-03T05:21:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T20:54:00.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:24.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.